These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1056 related articles for article (PubMed ID: 31027899)

  • 1. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
    Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
    Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer.
    Baiocchi G; Mantoan H; Gonçalves BT; Faloppa CC; Kumagai LY; Badiglian-Filho L; da Costa AABA; De Brot L
    Ann Surg Oncol; 2020 May; 27(5):1589-1594. PubMed ID: 31686340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
    Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
    Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
    Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
    Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
    Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer.
    Touhami O; Trinh XB; Gregoire J; Sebastianelli A; Renaud MC; Grondin K; Plante M
    Gynecol Oncol; 2015 Jul; 138(1):41-5. PubMed ID: 25891803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
    Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
    Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy.
    Bollino M; Geppert B; Lönnerfors C; Falconer H; Salehi S; Persson J
    Int J Gynecol Cancer; 2020 Mar; 30(3):339-345. PubMed ID: 32075897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
    Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.